TB Research

Interleukin-1 receptor antagonist is a conserved early factor for exacerbating tuberculosis susceptibility

Ophelia V. Lee, Daisy X. Ji, Bruce A. Rosa, David L. Jaye, Sara Suliman, Makedonka Mitreva, Cem Gabay, Russell E. Vance, et al. (9 authors)

bioRxiv (Cold Spring Harbor Laboratory) · 2023-11

Abstract

Summary Mycobacterium tuberculosis ( Mtb ) causes 1.25 million deaths a year. However, tuberculosis (TB) pathogenesis remains poorly understood and is not fully recapitulated in standard mouse models. Here we find that gene signatures from three different Mtb -susceptible mouse models predict active TB disease in humans significantly better than a signature from resistant C57BL/6 (B6) mice. Conserved among susceptible mice, non-human primates, and humans, but largely absent from B6 mice, was Mtb -induced differentiation of macrophages into an Spp1 + differentiation state. Spp1 + macrophages expressed high levels of immunosuppressive molecules including IL-1 receptor antagonist (IL-1Ra). IL-1Ra was previously reported to cause Mtb susceptibility in one mouse model, but whether IL-1Ra is broadly important remains uncertain. Here we report that enhancement of IL-1 signaling via deletion of IL-Ra promoted bacterial control across three susceptible mouse models. We found IL-1 signaling amplified production of multiple cytokines by lymphoid and stromal cells, providing a multifactorial mechanism for how IL-1 promotes Mtb control. Our results indicate that myeloid cell expression of immunosuppressive molecules, in particular IL-1 receptor antagonist, is a conserved early mechanism limiting Mtb control in mice, non-human primates, and humans.

MeSH terms

  • Biology
  • Immunology
  • Myeloid
  • Signal transduction
  • Mycobacterium tuberculosis
  • Inflammation
  • Cytokine
  • Mechanism (biology)
  • Receptor
  • Tuberculosis
  • Cell biology